Global reach: The top 25 biopharma companies in the world
Everyone likes to see a quick update on the list of the top companies in the industry, and the latest breakdown on big biopharma from GlobalData marked an opportunity I’m not going to let pass.
Of note, the data outfit flagged the debut of a Chinese company in the top 25 list. Chances are, we’ll be seeing others join it as the industry undergoes a tidal shift toward Asia.
Other highlights include a significant drop in market cap for Celgene $CELG as it lost favor with investors and now tries to win some market respect back.
For those of you who like comparisons, you would have to add the top 4 companies on the list — the global players J&J, Pfizer, Roche and Novartis — to come up with one company big enough to rival Apple’s $1 trillion market cap.
We did slightly rearrange this list to include a chart with updated market caps, so you could give it all some careful thought. Add them all up, and the sum of the 25 parts comes to $2.9 trillion. The distance from top to bottom marks a Grand Canyon of financial scale and reach. But what’s interesting is how this list could change in the next 5 years.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.